Codexis, Inc. (NASDAQ:CDXS) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET
Company Participants
Brendan Strong - Argot Partners
Dr. Stephen Dilly - President and Chief Executive Officer
Kevin Norrett - Chief Operating Officer
Ross Taylor - Chief Financial Officer
Conference Call Participants
Chad Wiatrowski - Cowen and Company
Matthew Hewitt - Craig-Hallum Capital Group
Operator
Welcome to the Codexis Third Quarter 2022 Earnings Conference Call. At this time, all participants are in listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions]
At this time, I will now turn the conference over to Brendan Strong from Argot Partners, please go ahead.
Brendan Strong
Thank you, operator. With me today are Dr. Stephen Dilly, Codexis' President and Chief Executive Officer; Kevin Norrett, Chief Operating Officer; and Ross Taylor, Chief Financial Officer. During this call, management will be making a number of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including our guidance for 2022 revenue, product revenues and gross margin on product revenues, as well as our strategies and prospects for revenue growth and successful execution of current and future programs and partnerships.
To the extent that statements contained in the call are not descriptions of historical facts regarding Codexis, they are forward-looking statements reflecting the beliefs and expectations of management as of the statement date, November 3rd, 2022. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are in some cases beyond Codexis' control and that could materially affect actual results.
Additional information about factors that could materially affect actual results can be found in Codexis' Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 28th, 2022 and on Form 10-Q filed with the SEC on, August 5th, 2022, including under the caption Risk Factors and in Codexis' other periodic reports filed with the SEC. Codexis expressly disclaims any intent or obligation to update these forward-looking statements except as required by-law.
I'll now turn the call over to Stephen.
Dr. Stephen Dilly
Thank you, Brendan and thanks to everyone for joining. Since our second quarter earnings call, we've been working to refine Codexis strategy by assessing the markets where Codexis and our proprietary CodeEvolver platform have a clear competitive advantage. This review of Codexis ongoing programs enable us to make intentional choices about where we are best equipped to drive long-term success and increase market penetration and ultimately where we should focus our resources.